Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.

Daltro, Pâmela Santana; Alves, Paula Santana; Castro, Murilo Fagundes de; Azevedo, Carine Machado; Vasconcelos, Juliana Fraga; Allahdadi, Kyan James; Freitas, Luiz Antonio Rodrigues de; Souza, Bruno Solano de Freitas; Santos, Ricardo Ribeiro dos; Soares, Milena Botelho Pereira; Macambira, Simone Garcia.
Artículo en Inglés | ARCA | ID: arc-13255

Documentos relacionados

  1. Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.
  2. Are targeted therapies for diabetic cardiomyopathy on the horizon?
  3. Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms.
  4. Cell death-inducing DFFA-like effector C/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation.
  5. Crosstalk between Sodium-Glucose Cotransporter Inhibitors and Sodium-Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases.
  6. Cardiorespiratory fitness in patients with type 2 diabetes: A missing piece of the puzzle.
  7. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
  8. Critical role of the epicardium in mediating cardiac inflammation and fibrosis in patients with type 2 diabetes.
  9. Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.
  10. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis.